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"Congestion": An Infrequent Feature in Patients with Chronic
Heart Failure on Therapy
Syed M. Jafri, MD,* Jeffrey B. Lakier, MD,^ Howard S. Rosman, MD,' and Sidney
Goldstein, MD^

The clinical presentation of chronic heart failure has changed with advances in therapy, and the
physical findings of congestion are now inconsistently present. To determine the clinical signs of
congestion, we studied the clinicalfindingsof 44 patients who had chronic heartfailure and abnormal
left ventricular ejection fractions (23 ± 10%). Signs qf pulmonary edema manifested as rales were
absent in all patients in New York Heart Association (NYHA) classes I and II, in 66% of patients in
NYHA class III, and in 14% of patients in NYHA class IV. Signs of right heart failure manifested as
elevated jugular venous pressure with or without peripheral edema were absent in 84% ofNYHA class
I and 66% ofNYHA class III patients. This study indicates that a majority ofpatients in NYHA cla.s.'tes I
through III can have impaired left ventricular performance without signs of congestion. The clinical
diagnosis of heart failure can no longer depend on evidence of "congestion" since these signs are
absent in many patients. (Henry Ford Hosp Med J 1986:34:160-2)

T

he term congestive heart failure was derived from the common clinical manifestations of "congestion" in heart failure
(1), Until the 1950s, when effecdve therapy for this condition
was not available, patients with overt fluid retention were commonly encountered. The recognition and management of
chronic heart failure have evolved in the past two decades. Noninvasive techniques have resulted in earlier recognition of
patients with impaired left ventricular function. Increased understanding of the pathophysiology of heart failure and improvements in its management have altered the clinical picture
ofthese padents. Amelioration of symptoms is achieved (2), and
"congestion" or fluid retention is no longer a consistent feature.
We evaluated the clinical signs and indices of left ventricular
performance in 44 padents with chronic heart failure who were
on therapy.

Methods
Forty-four patients with chronic heart failure were evaluated
prior to entry into trials with inotropic or vasodilator drugs. The
symptoms and signs of heart failure were assessed by one of the
investigators. The patients were categorized into four groups according to the 1953 New York Heart Association (NYHA) functional classification (3). The presence of audible moist rales was
considered proof of clinically evident pulmonary edema (4).
Jugular venous pressure was measured with the patient positioned at a 45° angle, and an elevated pressure (mean jugular
venous pressure > 7 cm H-,0) with or without hepatomegaly and
peripheral edema indicated right heart failure. The presence of
pleural effusion was also noted. (Since pleural effusion can be a
manifestation of both right-sided and left-sided heart failure,
this factor was not included in data analysis.) All patients had
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exercise intolerance, cardiomegaly, and an S3 gallop. Patients
were excluded if they had a recent myocardial infarction, exercise-limited angina, unstable angina pectoris, systolic blood
pressure > 180 mm Hg, diastolic blood pressure > 100 mm Hg,
primary unconected valvular disease, primary lung disease, and
hepatic or renal dysfunction.
Radionuclide gated blood pool scintigraphy was used in the
left anterior oblique at 45° and in anterior projections to calculate the left ventricular ejection fraction. Left ventricular ejection fraction was obtained by the automatic edge detection
program available in the MDS system. Cardiothoracic ratio was
calculated from the posterior-anterior chest roentgenogram by
dividing the maximal width of the heart by the maximal width of
the chest at the level of the dome of the right hemidiaphragm.
Exercise treadmill studies were performed on 43 patients using a
modification of the Naughton protocol to an end point of fatigue
or dyspnea.
In 14 of the 43 patients, right heart catheterization data
were obtained using a #7 thermodiludon catheter. All patients
were receiving diuretics at the initial evaluation but were not
on vasodilators as protocol for entry into drug trials. The
data of clinical findings were analyzed by the chi-square test,
and P < 0.05 was considered statistically significant.
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Results
Patients included 33 men and 11 women with a mean age of
57.8 years. The etiology for heart failure was idiopathic cardiomyopathy in 25 patients and coronary artery disease in 18 patients. One patient had had a previous aortic valve replacement.
Physical findings
The physicalfindingsare shown in the Figure. Signs of pulmonary edema were absent in those patients in NYHA classes 1
and II; 66% of NYHA class III and 20% of NYHA class IV patients also did not have clinical evidence of pulmonary edema.
Signs of right heart failure were absent in 84% of NYHA class 11
patients, and signs of pulmonary edema and right heart failure
(P < 0.001) were absent in 66% of NYHA class III patients.
Pleural effusion was evident in 19% of NYHA class 111 and 43%
of NYHA class IV patients.
Indices of left ventricular performance
The results of noninvasive and invasive tests of left ventricular
function are summarized in the Table. The left ventricular ejection fraction (LVEF) was 23 ± 10%; exercise test time (ETT)
was 434 ± 278 seconds; and cardiothoracic ratio (CTR) was
0.58 ± 0.08 for the group. LVEF and ETT decreased and CTR
increased with higher NYHA scores. Hemodynamic data were
available in 14 of these patients (NYHA class 111 and IV patients). The cardiac indices were low (1.9 ± 0.06 L/min/m-) and
pulmonary wedge pressures were elevated (29 ± 8 mm Hg) in
all patients.

Discussion
For the past two centuries evidence of "congestion" has been
considered a hallmark and prerequisite for the diagnosis of heart
failure (1). Congestive heart failure was an accurate term when
first introduced, since patients frequently had persistent signs of
fluid retention because of ineffective therapy. This study examines the prevalence of congestion with current therapy in patients with chronic heart failure and documented left ventricular
dysfunction.
A better understanding of the pathophysiologic derangements
in heart failure has led to new pharmacologic approaches, resulting in effective drug therapy. The emergence of potent diuretics, vasodilators, newer inotropic agents, and advances in
cardiac surgery have changed the clinical picture of these patients. Although a uniformly favorable change in the prognosis
has not occurred (5,6) with long-term administration of inotropic (7) and vasodilator drugs, patients with severe heart
failure frequently die of sudden death rather than progressive
heart failure (8). Padents with heart failure have signs of congestion if they have received inadequate therapy or are refractory to
conventional therapeutic approaches. The patients included in
our study were receiving diuretics, which partly accounts for the
low incidence of clinical evidence of "congestion" in all but
NYHA class IV patients. The overall incidence may be even
lower with the use of inotropic and vasodilator dmgs. We did not
include the radiologic features of congestion in our analysis
since our study was an attempt to define the prevalence of the
bedside signs of congestion. Engler et al (9) grouped patients
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Figure—Congestion/lack of congestion in chronic heartfailure.
Hatched bars = signs ofpulmonary edema. Open bars = signs
of right heart failure.

Table
Clinical and Hemodynamic Characteristics
NYHA class
1
II
111
IV
Patients (No.)
3
18
16
7
LVEF %
38 ± 14
25 ± 10
22 ± 10
19 ± 6
Cardiothoracic
O.IO
ratio*
0.54
0.06 0.55
0.07 0.59
0.07 0.63
136
ETT (sec)*
135
560
246
400
266
118
585
Cardiac index*
—
1.93 ± 0.06
2.0 ± 0.06
(L/min/m-)
Right atrial pressure* (mm Hg)
16
Pulmonary wedge
pressure* (mm Hg
27 ± 10
30
*Values expressed as mean ± standard deviation.
ETT = exercise test time, LVEF — lefl ventricular ejection fraction, and NYHA
New York Heart A.s.sociation.

with chronic heart failure according to their exercise tolerance.
Patients with poor exercise capacity and larger cardiothoracic
rados had a higher prevalence of clinical and radiologic signs of
congestion, which were absent in a substantial number of patients with mild or moderate symptoms.
The pulmonary wedge pressures were elevated in all our
patients (NYHA classes 111 and IV), although some of these
patients had no signs of pulmonary edema. Patients with longstanding heart failure can have chronically elevated left atrial
pressures without experiencing edema (10). These patients have
dyspnea on exertion without audible rales. An increased capacity of the pulmonary lymphatics to remove interstitial fluid has
been suggested as an explanation for the lack of alveolar edema
and audible rales in these patients.
It is apparent from our study that only a few patients with
NYHA class I , II, or III heart failure have features of congestion
despite exercise intolerance and abnormal ejection fractions and
hemodynamics. Chronic heart failure is thus a common clinical
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manifestation associated with different forms of heart disease,
with "congestion" infrequently encountered in patients seen in
clinical practice today.

References
1. Jafri SM, Lakier JB. Rosman HS, Goldstein S. Prevalence of congestion in
chronic heart failure (Editorial). Chest 1986 (in press),
2. Maskin CS, Forman R. Klein NA, Sonnenblick EH, LeJemtel TH. Longterm amrinone therapy in patients with severe heart failure: Drug dependent hemodynamic benefits despite progression of di.sea.se. Am J Med 1982:72:113-8.
3. The Criteria Committee of the New York Heart Association. Diseases of
the heart and blood vessels. 6th ed. Boston: Little, Brown and Co, 1953:112-3.
4. Braunwald E. Heart disease. Philadelphia: W.B. Saunders and Company,
1984:496.

162 Henry Ford Hosp Med J—Vol 34, No 3, 1986

5. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural
history of congestive heart failure: The Framingham study. N Engl J Med
1971;285:1441-6.
6. Franciosa JA, Wiien M, Ziesche S, Cohn JN. Survival in men with severe
chronic left ventricular failure due to either coronary artery disease or idiopathic
dilated cardiomyopathy. Am J Cardiol 1983;51:831-6.
7. Sonnenblick EH, Mancini D M , LeJemtel TH. New positive inotropic drugs for the treatment of congestive heart failure. Am J Cardiol
1985;55:4IA-44A.
8. Unverferth DV, Magorien RD, Moeschberger ML, Baker PB, Fetters JK,
Leier CV. Factors influencing the one-year mortality of dilated cardiomyopathy.
Am J Cardiol 1984;54:147-52.
9. Engler R, Ray R, Higgins CB, et al. Clinical assessment and follow-up of
functional capacity in patients with chronic congestive cardiomyopathy. Am J
Cardiol 1982;49:1832-7.
10. Tumer AF, Lau FYK, Jacobson G. A method for the estimation of pulmonary venous and arterial pressures from the routine chest roentgenogram. Am
J Roentgenol, Radium TherNucl Med 1972:116:97-106,

Chronic Heart Failure—Jafri et al

